Moreover, in a study of HCC patients receiving PD-1/PD-L1 inhibitors, patients without PD-L1+ CTCs had a worse ORR than patients with PD-L1+ CTCs (22). The gene discussed is CD274; the disease is hepatocellular carcinoma.